Logo image of ALCE

ALTERNUS CLEAN ENERGY INC (ALCE) Stock Fundamental Analysis

NASDAQ:ALCE - Nasdaq - US02157G2003 - Common Stock - Currency: USD

0.226  -0.06 (-20.65%)

After market: 0.17 -0.06 (-24.78%)

Fundamental Rating

0

ALCE gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of ALCE have multiple concerns. ALCE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCE has reported negative net income.
In the past year ALCE had a positive cash flow from operations.
ALCE Yearly Net Income VS EBIT VS OCF VS FCFALCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

ALCE has a Return On Assets of -102.44%. This is amonst the worse of the industry: ALCE underperforms 89.47% of its industry peers.
Industry RankSector Rank
ROA -102.44%
ROE N/A
ROIC N/A
ROA(3y)-12.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCE Yearly ROA, ROE, ROICALCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 100

1.3 Margins

ALCE has a Gross Margin of 76.17%. This is in the better half of the industry: ALCE outperforms 78.95% of its industry peers.
ALCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCE Yearly Profit, Operating, Gross MarginsALCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

ALCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCE has less shares outstanding
The debt/assets ratio for ALCE is higher compared to a year ago.
ALCE Yearly Shares OutstandingALCE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
ALCE Yearly Total Debt VS Total AssetsALCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

ALCE has an Altman-Z score of -3.26. This is a bad value and indicates that ALCE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.26, ALCE is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.26
ROIC/WACCN/A
WACC4.11%
ALCE Yearly LT Debt VS Equity VS FCFALCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.34 indicates that ALCE may have some problems paying its short term obligations.
ALCE has a worse Current ratio (0.34) than 89.47% of its industry peers.
A Quick Ratio of 0.34 indicates that ALCE may have some problems paying its short term obligations.
The Quick ratio of ALCE (0.34) is worse than 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
ALCE Yearly Current Assets VS Current LiabilitesALCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

ALCE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22771.43%.
EPS 1Y (TTM)-22771.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCE Yearly Revenue VS EstimatesALCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCE Price Earnings VS Forward Price EarningsALCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCE Per share dataALCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTERNUS CLEAN ENERGY INC

NASDAQ:ALCE (2/11/2025, 8:05:01 PM)

After market: 0.17 -0.06 (-24.78%)

0.226

-0.06 (-20.65%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.16%
Inst Owner Change0%
Ins Owners0.24%
Ins Owner Change32.61%
Market Cap1.33M
AnalystsN/A
Price TargetN/A
Short Float %1.45%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF 0.25
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-31.74
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)0.91
OCFY404.45%
SpS3.82
BVpS-14.01
TBVpS-15.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.17%
FCFM N/A
ROA(3y)-12.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -3.26
F-Score4
WACC4.11%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22771.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-935.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y357.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3403%
OCF growth 3YN/A
OCF growth 5YN/A